Nicky PellegrinoNicky Pellegrino

Health writer·New Zealand Listener·

20 Jul, 2026 06:06 PM4 mins to read

Subscribe to listenAccess to Herald Premium articles require a Premium subscription. Subscribe now to listen.Subscribe now

SaveShare this article

Reminder, this is a Premium article and requires a subscription to read.

Copy LinkEmailFacebookTwitter/XLinkedInReddit

The liver is a highly sensitive organ, but tends to soldier on and not display any sign of distress until it is in very poor shape. Photo / Getty Images

Despite being the most common liver disease in the developed world, affecting up to one in three adults, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) isn’t getting enough attention. The non-catchy name probably isn’t helping (it used to be known as non-alcoholic fatty liver) and an international review has found
no country is well enough prepared to manage a health problem that will affect an estimated 1.8 billion people by 2050.

SaveShare this article

Reminder, this is a Premium article and requires a subscription to read.

Copy LinkEmailFacebookTwitter/XLinkedInReddit